PMC:7377212 / 6920-7155 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T13","span":{"begin":131,"end":136},"obj":"Body_part"}],"attributes":[{"id":"A13","pred":"fma_id","subj":"T13","obj":"http://purl.org/sig/ont/fma/fma63083"}],"text":"Paris, France [9] 53 M Dexamethasone 20 mg·day−1 days 1–5, 10 mg·day−1 days 6–10 Typical COVID-19 (-) NR (-) 0.89 (-) BAL PCR (-), Serum PCR (-), BDG (+) \u003e500 NR No host factor Putative only if BAL GM cut-off lowered to \u003e0.8 None Alive"}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T12","span":{"begin":131,"end":136},"obj":"Body_part"}],"attributes":[{"id":"A12","pred":"uberon_id","subj":"T12","obj":"http://purl.obolibrary.org/obo/UBERON_0001977"}],"text":"Paris, France [9] 53 M Dexamethasone 20 mg·day−1 days 1–5, 10 mg·day−1 days 6–10 Typical COVID-19 (-) NR (-) 0.89 (-) BAL PCR (-), Serum PCR (-), BDG (+) \u003e500 NR No host factor Putative only if BAL GM cut-off lowered to \u003e0.8 None Alive"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T106","span":{"begin":89,"end":97},"obj":"Disease"}],"attributes":[{"id":"A106","pred":"mondo_id","subj":"T106","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"Paris, France [9] 53 M Dexamethasone 20 mg·day−1 days 1–5, 10 mg·day−1 days 6–10 Typical COVID-19 (-) NR (-) 0.89 (-) BAL PCR (-), Serum PCR (-), BDG (+) \u003e500 NR No host factor Putative only if BAL GM cut-off lowered to \u003e0.8 None Alive"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T50","span":{"begin":23,"end":36},"obj":"Chemical"},{"id":"T51","span":{"begin":102,"end":104},"obj":"Chemical"},{"id":"T52","span":{"begin":118,"end":121},"obj":"Chemical"},{"id":"T53","span":{"begin":159,"end":161},"obj":"Chemical"},{"id":"T54","span":{"begin":194,"end":197},"obj":"Chemical"},{"id":"T55","span":{"begin":198,"end":200},"obj":"Chemical"}],"attributes":[{"id":"A50","pred":"chebi_id","subj":"T50","obj":"http://purl.obolibrary.org/obo/CHEBI_41879"},{"id":"A51","pred":"chebi_id","subj":"T51","obj":"http://purl.obolibrary.org/obo/CHEBI_145751"},{"id":"A52","pred":"chebi_id","subj":"T52","obj":"http://purl.obolibrary.org/obo/CHEBI_64198"},{"id":"A53","pred":"chebi_id","subj":"T53","obj":"http://purl.obolibrary.org/obo/CHEBI_145751"},{"id":"A54","pred":"chebi_id","subj":"T54","obj":"http://purl.obolibrary.org/obo/CHEBI_64198"},{"id":"A55","pred":"chebi_id","subj":"T55","obj":"http://purl.obolibrary.org/obo/CHEBI_74120"},{"id":"A56","pred":"chebi_id","subj":"T55","obj":"http://purl.obolibrary.org/obo/CHEBI_27680"}],"text":"Paris, France [9] 53 M Dexamethasone 20 mg·day−1 days 1–5, 10 mg·day−1 days 6–10 Typical COVID-19 (-) NR (-) 0.89 (-) BAL PCR (-), Serum PCR (-), BDG (+) \u003e500 NR No host factor Putative only if BAL GM cut-off lowered to \u003e0.8 None Alive"}

{"project":"LitCovid-PD-GlycoEpitope","denotations":[{"id":"T4","span":{"begin":198,"end":200},"obj":"GlycoEpitope"}],"attributes":[{"id":"A4","pred":"glyco_epitope_db_id","subj":"T4","obj":"http://www.glycoepitope.jp/epitopes/EP0510"}],"text":"Paris, France [9] 53 M Dexamethasone 20 mg·day−1 days 1–5, 10 mg·day−1 days 6–10 Typical COVID-19 (-) NR (-) 0.89 (-) BAL PCR (-), Serum PCR (-), BDG (+) \u003e500 NR No host factor Putative only if BAL GM cut-off lowered to \u003e0.8 None Alive"}

{"project":"LitCovid-sentences","denotations":[{"id":"T38","span":{"begin":0,"end":235},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Paris, France [9] 53 M Dexamethasone 20 mg·day−1 days 1–5, 10 mg·day−1 days 6–10 Typical COVID-19 (-) NR (-) 0.89 (-) BAL PCR (-), Serum PCR (-), BDG (+) \u003e500 NR No host factor Putative only if BAL GM cut-off lowered to \u003e0.8 None Alive"}